Cargando…

Success and failure of triptans

Sumatriptan and the newer triptans (zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan, frovatriptan and donitriptan) display high agonist activity at 5-HT(1B) and 5-HT(1D) receptors. Most triptans, but not all (donitriptan, frovatriptan and rizatriptan), also have a high affinity at th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saxena, Pramod R., Tfelt-Hansen, Peer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag Italia 2001
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611827/ http://dx.doi.org/10.1007/s101940170040

Ejemplares similares

Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment
por: Tfelt-Hansen, Peer
Publicado: (2011)

Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
por: Kogelman, Lisette J. A., et al.
Publicado: (2023)

All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)

Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001)

Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)

Selecting the preferred triptans
por: McCrory, Douglas C., et al.
Publicado: (2004)

Best Value for Money in Triptans
por: Curtiss, Frederic R.
Publicado: (2005)

Triptans and CGRP blockade – impact on the cranial vasculature
por: Benemei, Silvia, et al.
Publicado: (2017)

Triptans and troponin: a case report
por: Weder, Claudia R, et al.
Publicado: (2009)

What can be learned from the history of recurrence in migraine? A comment
por: Tfelt-Hansen, Peer
Publicado: (2009)

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)

CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)

Verisimilitude (or “truthlikeness”) as an alternative to pro and cons: migraine and cluster headache mechanisms
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010)

Does sumatriptan cross the blood–brain barrier in animals and man?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2009)

Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008)

Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Are the current IHS guidelines for migraine drug trials being followed?
por: Hougaard, Anders, et al.
Publicado: (2010)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Use of triptans for the control of headache in bacterial meningitis
por: Wiwanitkit, Viroj
Publicado: (2014)

Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016)

Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
por: Hu, Yong, et al.
Publicado: (2013)

Triptans in the Italian population: a drug utilization study and a literature review
por: Panconesi, Alessandro, et al.
Publicado: (2008)

The 5-HT(1F) receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
por: Tfelt-Hansen, Peer C., et al.
Publicado: (2012)

Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial
por: Tfelt-Hansen, Peer
Publicado: (2011)

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
por: Tfelt-Hansen, Peer
Publicado: (2007)

Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
por: Tfelt-Hansen, Peer
Publicado: (2007)

Triptans in clinical practice: the basic scientist’s point of view
por: Buzzi, M. Gabriella
Publicado: (2001)

Triptans: the experience of a clinical pharmacologist in clinical practice
por: Pini, Luigi Alberto, et al.
Publicado: (2001)

Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)

Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015)

Triptan-induced takotsubo syndrome: a case report
por: Somers-Edgar, Tiffany Joy, et al.
Publicado: (2023)

Out of Illness, Into Life: Pain Management and the Need for Triptans
por: Barbuto, John P.
Publicado: (2003)

Which Triptan? - Opportunity for Same or Better Outcomes at Lower Cost
por: Curtiss, Frederic R.
Publicado: (2004)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans
por: Franconi, Flavia, et al.
Publicado: (2014)

When to use frovatriptan in migraine?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011)

Permeability of dura mater: a possible link between cortical spreading depression and migraine pain? A comment
por: Tfelt-Hansen, Peer Carsten
Publicado: (2010)

Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment
por: Tfelt-Hansen, Peer C.
Publicado: (2009)

Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
por: Dowson, A. J., et al.
Publicado: (2005)

Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
por: Leroux, Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ioaqcq5a8gm483ipkui1pne32